Apart from pathological features, T2DM and AD share molecular mechanisms and potential targets, including insulin/IGF-1 signaling, GSK3β, inflammation, mitochondrial dysfunction, and the ApoE4 allele (Hamzé et al., 2022). The gene discussed is INS; the disease is type 2 diabetes mellitus.